(Hypertension. 2000;36:851.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-
Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase
From the MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Montreal, Quebec, Canada.
Correspondence to Ernesto L. Schiffrin, MD, PhD, FRCPC, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7. E-mail schiffe{at}ircm.qc.ca
Abstract—Omega-3 fatty acids (n-3
FAs) have been shown to exert a blood pressure–lowering effect in
hypertension, possibly in part by influencing vascular structure. We
previously demonstrated that n-3 FAs induce vascular smooth muscle cell
(VSMC) apoptosis, which could exert an effect on the structure
of blood vessels. In the present study, we investigated signaling
pathways through which n-3 FAs mediate apoptosis in VSMCs.
Cultured mesenteric VSMCs from Sprague-Dawley rats were stimulated with
docosahexaenoic acid (DHA), a representative n-3 FAs.
Morphological changes in apoptosis and DNA fragmentation were
examined with phase-contrast microscopy and fluorescence
microscopy with Hoechst 33342 staining. To clarify possible pathways of
apoptosis, we evaluated the expression of
phosphorylated p38 mitogen-activated protein
kinases, bax, bcl-2, cytochrome c, and peroxisome
proliferator-activated receptor-
(PPAR-) with Western
blot analysis. DHA treatment induced cell shrinkage, cell
membrane blebbing, and apoptotic bodies in VSMCs. DHA
time-dependently activated p38 mitogen-activated
protein kinases, bax, PPAR-, and cytochrome c, with
maximal effects obtained after 5 and 30 minutes and 1 and 3 hours,
respectively. SB-203580 and SB-202190, selective p38
inhibitors, reduced DHA-elicited apoptosis and
expression of PPAR- but had no effect on the expression of bax or
cytochrome c. The present results indicate that DHA
induces apoptosis in VSMCs through 
2 distinct mechanisms: (1)
a p38-dependent pathway that regulates PPAR- and (2) a
p38-independent pathway via dissipation of mitochondrial membrane
potential and cytochrome c release. The death-signaling
pathway stimulated by DHA may involve an integration of these multiple
pathways. By triggering VSMC apoptosis, DHA may play a
pathophysiological role in vascular remodeling in
cardiovascular disease.
Key Words: fatty acids • docosahexaenoic acid • apoptosis • cells • muscle, smooth, vascular • protein kinases
This article has been cited by other articles:
 |
|
 |
|
  J. Li, X.-L. Niu, and N. R. Madamanchi Leukocyte Antigen-related Protein Tyrosine Phosphatase Negatively Regulates Hydrogen Peroxide-induced Vascular Smooth Muscle Cell Apoptosis J. Biol. Chem., December 5, 2008; 283(49): 34260 - 34272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ruan, F. Zheng, and Y. Guan PPARs and the kidney in metabolic syndrome Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Delbosc, M. Glorian, A.-S. Le Port, G. Bereziat, M. Andreani, and I. Limon The Benefit of Docosahexanoic Acid on the Migration of Vascular Smooth Muscle Cells Is Partially Dependent on Notch Regulation of MMP-2/-9 Am. J. Pathol., May 1, 2008; 172(5): 1430 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ravaux, C. Denoyelle, C. Monne, I. Limon, M. Raymondjean, and K. El Hadri Inhibition of Interleukin-1{beta}-Induced Group IIA Secretory Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptors (PPARs) in Rat Vascular Smooth Muscle Cells: Cooperation between PPAR{beta} and the Proto-Oncogene BCL-6 Mol. Cell. Biol., December 1, 2007; 27(23): 8374 - 8387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Aires, A. Hichami, R. Filomenko, A. Ple, C. Rebe, A. Bettaieb, and N. A. Khan Docosahexaenoic Acid Induces Increases in [Ca2+]i via Inositol 1,4,5-Triphosphate Production and Activates Protein Kinase C{gamma} and -{delta} via Phosphatidylserine Binding Site: Implication in Apoptosis in U937 Cells Mol. Pharmacol., December 1, 2007; 72(6): 1545 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Lok, M. Allon, S. Donnelly, M. Dorval, B. Hemmelgarn, L. Moist, M. J. Oliver, M. Tonelli, and K. Stanley Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study Clinical Trials, August 1, 2007; 4(4): 357 - 367. [Abstract] [PDF]
|
|
|
|
 |
|
 C. A. Pfrommer, W. Erl, and P. C. Weber Docosahexaenoic acid induces ciap1 mRNA and protects human endothelial cells from stress-induced apoptosis Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2178 - H2186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zahradka, B. Wright, M. Fuerst, N. Yurkova, K. Molnar, and C. G. Taylor Peroxisome Proliferator-Activated Receptor {alpha} and {gamma} Ligands Differentially Affect Smooth Muscle Cell Proliferation and Migration J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, W. J. Esselman, D. B. Jump, and J. V. Busik Anti-inflammatory Effect of Docosahexaenoic Acid on Cytokine-Induced Adhesion Molecule Expression in Human Retinal Vascular Endothelial Cells Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4342 - 4347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin Peroxisome proliferator-activated receptors and cardiovascular remodeling Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1037 - H1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Guan Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clinical Nutrition, June 1, 2004; 79(6): 935 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lin, X. Zhu, F. L. Mclntee, H. Xiao, J. Zhang, M. Fu, and Y. E. Chen Interferon Regulatory Factor-1 Mediates PPAR{gamma}-Induced Apoptosis in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 257 - 263. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. L. Schiffrin, F. Amiri, K. Benkirane, M. Iglarz, and Q. N. Diep Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension Hypertension, October 1, 2003; 42(4): 664 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, D. Li, G. J Roberts, T. Saldeen, and J. L Mehta Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes Cardiovasc Res, July 1, 2003; 59(1): 7 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Engler, M. B. Engler, D. M. Pierson, L. B. Molteni, and A. Molteni Effects of Docosahexaenoic Acid on Vascular Pathology and Reactivity in Hypertension Experimental Biology and Medicine, March 1, 2003; 228(3): 299 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bousserouel, A. Brouillet, G. Bereziat, M. Raymondjean, and M. Andreani Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smooth muscle cells by interleukin-1{beta} J. Lipid Res., March 1, 2003; 44(3): 601 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iglarz, R. M. Touyz, F. Amiri, M.-F. Lavoie, Q. N. Diep, and E. L. Schiffrin Effect of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} Activators on Vascular Remodeling in Endothelin-Dependent Hypertension Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 45 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. N. Diep, F. Amiri, R. M. Touyz, J. S. Cohn, D. Endemann, M. F. Neves, and E. L. Schiffrin PPAR{alpha} Activator Effects on Ang II-Induced Vascular Oxidative Stress and Inflammation Hypertension, December 1, 2002; 40(6): 866 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fauconnet, I. Lascombe, E. Chabannes, G.-L. Adessi, B. Desvergne, W. Wahli, and H. Bittard Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells J. Biol. Chem., June 21, 2002; 277(26): 23534 - 23543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y Abeywardena and R. J Head Longchain n-3 polyunsaturated fatty acids and blood vessel function Cardiovasc Res, December 1, 2001; 52(3): 361 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hatae, M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe Prostacyclin-dependent Apoptosis Mediated by PPARdelta J. Biol. Chem., November 30, 2001; 276(49): 46260 - 46267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Simopoulos The Mediterranean Diets: What Is So Special about the Diet of Greece? The Scientific Evidence J. Nutr., November 1, 2001; 131(11): 3065S - 3073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. N. Diep and E. L. Schiffrin Increased Expression of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} in Blood Vessels of Spontaneously Hypertensive Rats Hypertension, August 1, 2001; 38(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Jones, X. Ding, and R. A. Daynes Nuclear Receptor Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Is Expressed in Resting Murine Lymphocytes. THE PPARalpha IN T AND B LYMPHOCYTES IS BOTH TRANSACTIVATION AND TRANSREPRESSION COMPETENT J. Biol. Chem., February 22, 2002; 277(9): 6838 - 6845. [Abstract] [Full Text] [PDF]
|
|